The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Inaccuracies Inherent in Dual-Energy X-Ray Absorptiometry In Vivo Bone Mineral Density Can Seriously Mislead Diagnostic/Prognostic Interpretations of Patient-Specific Bone Fragility
Abstract
SINCE ITS advent, noninvasive dual-energy X-ray absorptiometric (DXA) in vivo measurement of bone mineral density (BMD) has been accepted almost universally as the methodology of choice in the field of clinical bone fragility. More specifically, DXA generally is considered to be the prime, reliable assessor of the osteopenic/osteoporotic condition1-6 of bone fracture propensity,6-9 of correlations of measured BMD with fracture failure load of bones,10-17 and of the efficacy of remedial bone therapies.18-26 DXA also is held to be the standard against which newer, emerging alternative methods of bone quality assessment are evaluated.27, 28 However, despite the near ubiquitous clinical use of DXA-measured in vivo BMD and the widespread reliance on it, recently attention has been drawn to the prospect that BMD, per se, may not be the primary determinant of bone fracture risk. Reports of large reductions in vertebral fracture rates attributed to antiresorptive therapy, but without commensurate accompanying increases in BMD,20, 22, 24, 29, 30 have prompted suggestions7, 31 that BMD may not be homologous with bone strength and that other nondensity particulars may be as, or more, important in this respect. Notwithstanding the importance of the foregoing, certainly one of the most fundamental issues relevant to all aspects of bone densitometry and fragility studies and resultant in vivo diagnostic/prognostic interpretations relates to the growing number of investigations that have shown DXA-derived in vivo BMD to be subject to sizable inherent systematic inaccuracies that may adversely influence measurement outcomes.32-39 Clearly, the extent of such in vivo BMD inaccuracies and the dependence of them on soft-tissue anthropometric particulars are of salient import for patient-specific clinical DXA measurements.38, 39 Such BMD inaccuracies could seriously compromise the integrity of measurements undertaken to diagnose, monitor, and evaluate the osteopenic/osteoporotic condition and predictive bone fragility of any individual patient. Were this the case, reliance on DXA-derived BMD measurement values could lead to misinterpretations and erroneous assessments of the efficacy and/or quantitative effectiveness of drug and other therapeutic regimens intended to ameliorate the osteoporotic condition.32-41 Moreover, should large in vivo BMD inaccuracies pertain, clinical DXA investigations undertaken to delineate specific anthropometric, dietary, and/or therapeutic factors which may prove biologically causal or remedially effective in altering BMD and bone fracture propensity, could yield tenuous and/or misleading conclusions.38-41 These concerns are underscored by the findings of a considerable number of investigations: in situ/in vitro cadaveric DXA studies,10, 11, 17, 42 absorptiometrically realistic phantom DXA studies,40 simulation studies of replicated clinical in vivo bone-site particulars,38-41 and fundamental quantitative analyses of DXA methodology.34, 43 Collectively, these observations and results may be seen to constitute a formidable case for reevaluation of the reliability and accuracy of DXA-measured in vivo BMD. For these reasons, it is important to highlight and evaluate the evidence substantiating the presence of inherent clinical inaccuracies in DXA-measured in vivo BMD, assess the demonstrated extent of these inaccuracies, and draw attention to some of the consequential effects of these inaccuracies on bone densitometry in the clinical context. Inherent systematic inaccuracies in DXA BMD derive from the known inapplicability of planar DXA methodology to bone sites comprised of more than two absorptiometrically distinguishable components in the entire scan region of interest (ROI); the "two-component DXA limitation."32-35, 37-39 Yet, all in vivo bone sites are comprised of bone material, intraosseous soft tissue of some unspecified red/yellow marrow compositional mix, and some combination of lean muscle tissue and fat external to the bone that together constitute at least four absorptiometrically disparate components in the DXA scan ROI. Therefore, it is clear that in vivo bone-site reality does not and cannot strictly conform to or satisfy the two-component DXA restriction.38 This shortcoming is further exacerbated in any patient-specific case by the inability of DXA to assess the necessary particulars of the bone marrow composition. Further, in vivo DXA can neither determine the fat component (and its degree of inhomogeneity) within the lean extraosseous tissue along any X-ray path traversing bone material nor determine the quantitative extent to which the two-component DXA limitation fails to be satisfied in any given in vivo bone-site scan. A most serious consequence of the violation of this intrinsic two-component DXA limitation is the under- or overestimation of BMD. This is so because DXA methodology erroneously and unavoidably attributes to bone material any difference between the X-ray absorptio
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone density at various sites for prediction of hip fractures
Cummings, S. R., Browner, W., Cummings, S. R., Black, D. M., Nevitt, M. C., Browner, W., Genant, H. K., Cauley, J., Ensrud, K., Scott, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92555-8 · Cited by 2,446
Age-related reductions in the strength of the femur tested in a fall-loading configuration.
Courtney, A. C., Wachtel, E. F., Myers, E. R., & Hayes, W. C. (1995) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199503000-00008 · Cited by 301
Cited by
Peacock, M., Turner, C. H., Econs, M. J., & Foroud, T. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0464 · Cited by 468
Kontulainen, S., Sievänen, H., Kannus, P., Pasanen, M., & Vuori, I. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.12.2281 · Cited by 439
Self-citationPeriosteum: biology, regulation, and response to osteoporosis therapies
Allen, M. R., Hock, J. M., & Burr, D. B. (2004) · Bone · doi:10.1016/j.bone.2004.07.014 · Cited by 431
Shifting the focus in fracture prevention from osteoporosis to falls
Järvinen, T. L. N., Sievänen, H., Khan, K. M., Heinonen, A., & Kannus, P. (2008) · BMJ · doi:10.1136/bmj.39428.470752.ad · Cited by 410
Self-citationEffects of Resistance Exercise on Bone Health
Hong, A. R., & Kim, S. W. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.4.435 · Cited by 291
Metadata
- Authors
- Bolotin, H. H., & Sievänen, H.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-05-01
- Volume
- 16
- Issue
- 5
- Pages
- 799-805
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2007785067
- Cited by
- 185
- References
- 3
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inaccuracies Inherent in Dual-Energy X-Ray Absorptiometry In Vivo Bone Mineral Density Can Seriously Mislead Diagnostic/Prognostic Interpretations of Patient-Specific Bone Fragility. https://app.cochat.ai/papers/10.1359/jbmr.2001.16.5.799
- The paper
- Bolotin, H. H., & Sievänen, H. (2001). Inaccuracies Inherent in Dual-Energy X-Ray Absorptiometry In Vivo Bone Mineral Density Can Seriously Mislead Diagnostic/Prognostic Interpretations of Patient-Specific Bone Fragility. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.2001.16.5.799
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.